Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Intratumoral CV8102 in Patients With Advanced Melanoma, Squamous Cell Carcinoma of the Skin, Squamous Cell Carcinoma of the Head and Neck, or Adenoid Cystic Carcinoma

NCT03291002 is registered in ClinicalTrials.gov with CureVac as lead sponsor.

NCT NCT03291002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03291002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Intratumoral CV8102 in Patients With Advanced Melanoma, Squamous Cell Carcinoma of the Skin, Squamous Cell Carcinoma of the Head and Neck, or Adenoid Cystic Carcinoma
Lead sponsor
CureVac
Phase
Phase 1
Overall status
Unknown status
Start date
September 25, 2017
Completion date
February 28, 2023
Enrollment
98 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, adenoid cystic, carcinoma, squamous cell of head and neck, melanoma (skin), squamous cell carcinoma of the skin